Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 956 of 6351
-
Could your own stem cells ease incurable chest pain?
Disease control OngoingProspective, multi-center, 2:1 randomized (Treatment : Sham Control), sham-controlled, double-blinded trial to compare treatment using the CardiAMP cell therapy system to sham treatment Treatment Group: Subjects treated with aBMC using the CardiAMP cell therapy system Sham Con…
Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Double radiation attack on resistant prostate cancer enters human testing
Disease control Recruiting nowThis is a phase I dose-escalation study of 225Ac-J591 administered together with 177Lu-PSMA small molecule. Both drugs are designed to deliver radiation to prostate cancer cells; they are known as radionuclide conjugates (radiation linked to antibodies/molecules that recognize pr…
Phase 1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Keytruda may offer new hope for cervical precancer
Disease control Recruiting nowThis phase II trial studies the effect of pembrolizumab on cervical intraepithelial neoplasia. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and sprea…
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for teens with chronic migraines?
Disease control Recruiting nowTo find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.
Phase 3 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Double-Barreled attack: chemo plus targeted liver beads tested for stubborn colon cancer spread
Disease control OngoingNon-commercial, prospective, randomized, multicenter, national, phase II, open-label comparative clinical trial. The patients will be randomized in a 1: 1 ratio in two arms: Control arm. Systemic chemotherapy with FOLFOX6m + monoclonal Ab Experimental arm. Systemic chemotherapy…
Phase 2 • Sponsor: Grupo Espanol Multidisciplinario del Cancer Digestivo • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can beans beat obesity and colon cancer?
Prevention OngoingThis study tests whether a high-fiber diet based on legumes, such as dry beans, can lead to sustained reductions in obesity and colon cancer risk in persons at highest risk, namely overweight or obese, post-polypectomy patients.
Sponsor: Emory University • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
Chilling the body to save the lungs: new trial for ARDS
Disease control OngoingAcute Respiratory Distress Syndrome (ARDS) is a serious condition that occurs as a complication of medical and surgical diseases, has a mortality of \~40%, and has no known treatment other than optimization of support. Data from basic research, animal models, and retrospective st…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
New drug cocktail aims to wipe out hard-to-treat stomach cancer before surgery
Disease control Recruiting nowIn this research study, is studying how Liposomal Irinotecan in combination with the standard of care interventions FOLFOX, carboplatin paclitaxel, and radiation therapy affect gastroesophageal junction or esophagogastric cancer This research study involves the following study i…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug combo aims to extend life in tough bladder cancer cases
Disease control OngoingThis phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemci…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could your own stem cells ease Parkinson's? new trial results are in
Disease control CompletedThis is a randomized, double-blind, single center, phase 2 study to assess efficacy and safety of multiple HB-adMSCs vs Placebo for the treatment of Parkinson's disease. The trial includes a screening period of up to 4 weeks, a 32-week treatment period, and a safety Follow-up pe…
Phase 2 • Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New combo therapy shows promise for Hard-to-Treat cervical cancer
Disease control CompletedThe primary objective of the study is to estimate the clinical benefit of cemiplimab + ISA101b after progression on first line chemotherapy, as assessed by objective response rate (ORR). The secondary objectives of the study are: * To characterize the safety profile of cemiplim…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 26, 2026 15:18 UTC
-
Tailored IV fluids aim to shield kidneys during heart tests
Prevention Recruiting nowThe NEPTUNE triple-blind, active-placebo, adaptive, pragmatic, randomized trial aims to evaluate the effectiveness of a new intra-venous hydration strategy guided by left ventricular end-diastolic pressure (LVEDP), amount of contrast used, and baseline renal function, to prevent …
Sponsor: Montreal Heart Institute • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Light-Based test could spot ovarian cancer sooner
Diagnosis CompletedOvarian cancer is the eighth most common cause of cancer death in the world. Advanced stage at diagnosis is associated with lower survival rates, thus early detection appears to have an important role. Raman Spectroscopy is a non-invasive technique that uses the interaction of l…
Sponsor: University of Exeter • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Could less chemo be better? new trial aims to reduce treatment burden for brain lymphoma
Disease control OngoingThis phase III study investigates if a de-escalated induction treatment in newly diagnosed primary CNS lymphoma is superior to the standard MATRix protocol in terms of event free survival.
Phase 3 • Sponsor: Klinikum Stuttgart • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New combo shows promise in shrinking stomach tumors before surgery
Disease control CompletedMulticenter, open-label, non randomized, phase 2 trial in resectable gastric or gastroesophageal junction adenocarcinoma: Perioperative Treatment by Spartalizumab (PDR001) in Combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT)
Phase 2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
AI-Powered texts aim to help smokers beat the habit
Disease control CompletedThe goal of this research is to test the Adapt2Quit computer program that uses participant input (message rating on how much the text motivational message might influence one to quit smoking) to select and text motivational messages that are more likely to help a user stop smokin…
Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a wakefulness drug combat the crushing fatigue of myotonic dystrophy?
Symptom relief CompletedThe primary objective of this study is to evaluate the safety and efficacy of pitolisant compared with placebo in treating excessive daytime sleepiness (EDS) in patients with Myotonic Dystrophy Type 1 ages 18 to 65 years. The secondary objectives of this study are to assess the …
Phase 2 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Could blocking stress hormones shield the brain from Alzheimer's?
Disease control Recruiting nowCORT-X will examine if mitigation of stress-mediated pathogenesis of Alzheimer's disease (AD) is a feasible target for intervention in individuals at risk for this disease. This single-site (Baltimore, Maryland) phase II clinical trial is a 2-week, randomized, placebo-controlled …
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug duo shows promise for rare blood cancer
Disease control CompletedThis study is to analyze the efficacy of PD1 inhibitor and anti-CD38 antibody in relapsed or refractory NK/T-cell lymphoid malignancy. The investigational products of this study are cemiplimab (PD1 inhibitor) and isatuximab (anti-CD38 antibody). The rationale for the use of cemi…
Phase 2 • Sponsor: Won Seog Kim • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New immunotherapy cocktail targets Hard-to-Treat bowel cancer
Disease control OngoingThe purpose of this study is to assess the efficacy and safety of co-formulated pembrolizumab/quavonlimab versus other treatments in participants with MSI-H or dMMR Metastatic Stage IV Colorectal Cancer.
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC